Skip to main content

Table 8 Cumulative survival for Nomo stages in derivation and external validation cohorts

From: Nomograms to predict survival after colorectal cancer resection without preoperative therapy

  Training cohort Validation cohort Test cohort
  (Cumulative survival, 60 months, %) (Cumulative survival, 60 months, %) (Cumulative survival, 59 months, %)
Nomo stage CSS 95 % CI OS 95 % CI CSS 95 % CI OS 95 % CI CSS 95 % CI OS 95 % CI
Nomo 1 96.8 96.1–97.4 94.6 93.7–95.4 97.7 96.1–99.4 95.5 93.2–97.8 94.3 88.7–99.8 90.8 85.5–96.1
Nomo 2 94.0 93.1–95.0 88.1 86.9–89.3 92.9 90.0–95.8 87.1 83.4–90.9 94.0 91.5–96.6 89.0 86.5–91.4
Nomo 3 90.9 89.8–92.0 83.7 82.4–85.1 91.2 88.0–94.4 86.6 82.8–90.3 92.1 90.5–93.6 85.5 83.4–87.7
Nomo 4 87.1 85.8–88.4 76.1 74.5–77.7 88.1 84.4–91.7 78.9 74.4–83.4 87.4 84.5–90.3 76.5 73.5–79.5
Nomo 5 82.0 80.4–83.5 70.3 68.6–72.0 82.3 77.9–86.7 67.8 62.6–73.0 83.7 81.8–85.7 69.1 62.1–76.1
Nomo 6 74.2 72.4–75.9 59.0 57.2–60.9 73.6 68.5–78.7 59.4 54.0–64.8 76.1 73.9–78.4 60.1 56.9–63.3
Nomo 7 63.3 61.4–65.2 44.8 42.9–46.7 61.3 55.6–67.0 50.6 45.1–56.1 64.4 60.3–68.6 47.4 43.3–51.5
Nomo 8 43.6 41.6–45.6 32.6 30.9–34.4 50.8 44.8–56.8 32.7 27.5–37.9 49.9 46.9–53.0 31.8 27.9–35.7
Nomo 9 22.1 20.4–23.7 18.0 16.5–19.4 23.9 18.8–29.0 20.2 15.8–24.7 20.2 16.0–24.4 17.8 15.0–20.6
Nomo 10 5.7 4.7–6.6 4.8 4.0–5.6 8.4 5.2–11.6 7.3 4.5–10.2 6.3 3.9–8.6 3.8 1.3–6.3
Plog-rank for trend <0.0001   <0.0001   <0.0001   <0.0001   <0.0001   <0.0001  
  1. CSS cancer-specific survival, OS overall survival, Nomo Nomo stages